

A practical guide for providers on helping patients locate Corlanor (Ivabradine). Pharmacy strategies, workflow tips, alternatives, and tools for your practice.
If you prescribe Ivabradine for heart failure patients, you've likely received calls from patients (or their pharmacies) reporting that Corlanor is unavailable. This is a recurring challenge with specialty cardiac medications, and it can lead to treatment interruptions that put patients at risk.
This guide provides practical, actionable steps your practice can take to help patients maintain access to Ivabradine — from pharmacy selection to workflow integration.
Ivabradine is not in an FDA-listed shortage as of 2026. The availability challenge stems from its specialty status:
For a detailed analysis, see our provider shortage briefing.
Understanding the patient experience helps you provide better guidance:
This cycle is predictable — and preventable. By front-loading the pharmacy identification step at the point of prescribing, you can eliminate most of this friction.
Create and maintain a list of 3-5 pharmacies in your service area that reliably stock Ivabradine. Include:
Share this list with patients at the time of prescribing — don't wait for them to encounter problems. Print it on a card or include it in their after-visit summary.
When a patient calls reporting they can't find Ivabradine, your staff can use Medfinder to quickly search for pharmacies with current stock near the patient's location. This turns a 30-minute phone chain into a 2-minute search.
Consider bookmarking medfinder.com/providers on workstations where staff handle pharmacy callbacks.
Unless there's a documented clinical reason for brand-name Corlanor, write prescriptions allowing generic Ivabradine substitution. This:
Generic Ivabradine is available in the same 5 mg and 7.5 mg tablet strengths and is AB-rated to Corlanor.
Since most payers require PA for Ivabradine, submit the prior authorization before the patient goes to the pharmacy. Key documentation to include upfront:
Many EHR systems support PA submission directly. Having a templated PA letter for Ivabradine saves significant staff time.
If your practice receives manufacturer samples of Corlanor, keep a small supply available for situations where:
Even a 7-14 day bridge supply can prevent a treatment gap that leads to symptom worsening or hospitalization.
If a patient truly cannot access Ivabradine for an extended period, clinical alternatives to consider:
For a patient-facing guide on alternatives, see alternatives to Corlanor.
Integrate cost conversations into the prescribing workflow:
Ivabradine availability challenges are a logistics problem, not a supply problem — and logistics problems have logistics solutions. By integrating pharmacy identification, proactive PA submission, and patient education into your prescribing workflow, you can prevent most treatment interruptions before they happen.
Tools like Medfinder make it easy for your staff to quickly identify stocked pharmacies, and manufacturer programs can address cost barriers. With a few workflow adjustments, you can keep your heart failure patients on this important guideline-directed therapy.
For more Corlanor resources, see our provider shortage briefing, drug interaction guide, and provider cost navigation guide.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.